1. Exploration of biomarkers for efficacy evaluation of traditional Chinese medicine syndromes of acute exacerbation of chronic obstructive pulmonary disease based on metabolomics
   Zhang Hailong et al, 2024, Frontiers in Pharmacology CrossRef
2. Lysophosphatidylcholine induces oxidative stress and calcium‐mediated cell death in human blood platelets
   Pooja Yadav et al, 2024, Cell Biology International CrossRef
3. Non-Targeted Serum Lipidomics Analysis and Potential Biomarkers of Laryngeal Cancer Based on UHPLC-QTOF-MS
   Haoyue Wang et al, 2022, Metabolites CrossRef
4. Characterization of Lipid Alterations by Oncogenic PIK3CA Mutations Using Untargeted Lipidomics in Breast Cancer
   Jae Hun Jung et al, 2023, OMICS: A Journal of Integrative Biology CrossRef
5. Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival
   Kyung-Hee Kim et al, 2017, Oncotarget CrossRef
6. A validated LC–MS/MS method for the determination of homocysteic acid in biological samples
   R. Gurke et al, 2019, Journal of Pharmaceutical and Biomedical Analysis CrossRef
7. Lysophosphatidylcholine induces expression of genes involved in cholesterol biosynthesis in THP-1 derived macrophages
   Min Ho Cha et al, 2018, Steroids CrossRef
8. Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging
   Anya B. Zhong et al, 2022, Frontiers in Molecular Biosciences CrossRef
9. Sterigmatocystin induced cytotoxicity and disturbed lipid metabolism
   Youyou Zhou et al, 2023, Journal of Agriculture and Food Research CrossRef
10. Identification of Metabolite Biomarkers for Gout Using Capillary Ion Chromatography with Mass Spectrometry
    Li Cui et al, 2017, Analytical Chemistry CrossRef
11. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip
    Jong-Min Park et al, 2020, Journal of the American Society for Mass Spectrometry CrossRef
12. The mechanisms of lysophosphatidylcholine in the development of diseases
    Panpan Liu et al, 2020, Life Sciences CrossRef
13. Low-mass-ion discriminant equation (LOME) for ovarian cancer screening
    Jun Hwa Lee et al, 2016, BioData Mining CrossRef
14. Anti-melanoma activity of Forsythiae Fructus aqueous extract in mice involves regulation of glycerophospholipid metabolisms by UPLC/Q-TOF MS-based metabolomics study
    Jiaolin Bao et al, 2016, Scientific Reports CrossRef
15. Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry
    Janos Schmidt et al, 2020, Oncotarget CrossRef
16. Optical analysis of homocysteine metabolites using vibrational spectroscopy
    Mingzhou Chen et al, 2020, OSA Continuum CrossRef
17. Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long‐chain acyl‐coenzyme A synthase 5
    Linlin Zhang et al, 2023, Clinical and Translational Medicine CrossRef
18. Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort
    Zedan Zhang et al, 2024, iScience CrossRef
19. Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare
    Jun Hwa Lee et al, 2018, EPMA Journal CrossRef
20. “Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
    Lingjun Xiao et al, 2024, Cancer Communications CrossRef